Latest Cancer News

BRCA Mutations Influence Ovarian Cancer Outcomes (01-27-2012)
Among women with ovarian cancer, those who have a BRCA1 or BRCA2 gene mutation appear to have better overall survival than those who do not have a BRCA gene mutation. These results were published in the... Continue Reading

Drug May Delay Need for Prostate Cancer Treatment (01-26-2012)
Among men who choose active surveillance for early-stage prostate cancer, Avodart® (dutasteride) may delay cancer progression and the need for cancer treatment. These results were published in The Lancet. The... Continue Reading

Abnormal Chromosome Influences Outcome of Rare Brain Tumor (01-25-2012)
For patients with uncommon brain tumors known as oligodendrogliomas, the presence of a specific chromosomal abnormality is linked with a better prognosis and responsiveness to chemotherapy. These results... Continue Reading

More Cancer News

Events

Tower Oncology’s Cancer Support Network Brings New Services to West Side
Organizations partner to offer full range of cancer support and education to meet a growing need. Read more…


Tower Hematology Oncology Medical Group Named Fight Back Chair For American Cancer Society’s Relay for Life Event in Beverly Hills
Cancer treatment center seeks volunteers, donations for April 30 cancer support fundraiser
Read more…

Tower News

Tower Hematology Oncology Medical Group has been awarded a three-year term of accreditation in computed tomography (CT) and positron emission tomography (PET) as the result of a recent review by the American College of Radiology (ACR). CT scanning — sometimes called CAT scanning — is a noninvasive medical test that helps physicians diagnose and tailor treatments for various medical conditions. Learn more…

Locations

Tower Hematology Oncology Medical Group
9090 Wilshire Boulevard
Suite 200
Beverly Hills, CA 90211
Phone: (310) 888-8680
Click here for map